Lysosomal Acid Lipase (LAL) Deficiency Registry

Recruiting now

Conditions studied: Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, LIPA Deficiency, LAL-Deficiency

In brief

This is an observational, multi-center, international disease registry designed to collect longitudinal data and create a knowledge base that will be utilized to improve the care and treatment of patients with LAL Deficiency. Participation in the Registry by both physicians and patients is voluntary.

Key facts

Study ID
NCT01633489
Run by
Alexion Pharmaceuticals, Inc.
People needed
300
Starts
2013-05-30
Expected to finish
2029-08-30
Last updated by the study team
2026-03-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.